Webinar Information and Registration
Multiple Myeloma: Overview and Therapeutic Approaches
Wednesday, August 14, 2013, 2-3 pm EDT
|Register Now (Webinar Already Occurred)|
Wednesday, September 11, 2013, 1-2 pm EDT
After registration, you will receive an e-mail confirmation with instructions for joining the webinar.
Accreditation for Pharmacists
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This activity provides 1 hour (0.1 CEU) of continuing pharmacy education credit (activity # 0204-0000-13-459-L01-P).
Methods and Format
This is a live web-based activity consisting of audio, presentation slides, and an activity evaluation tool. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit. Participants may print their official statements of continuing pharmacy education credit immediately following the activity. This activity is provided free of charge. View full CE processing instructions.
This continuing pharmacy education activity was planned to meet the needs of health system pharmacists, especially those interested in hematology, oncology, new drug therapies, preventing resistance, and quality improvement.
Multiple myeloma is the second most frequently diagnosed hematologic malignancy in the United States, affecting 20,000 individuals each year. Diagnosis can be a challenge because the condition can present with any or all of a long list of possible symptoms. In addition, it is more prevalent in the elderly population, and some symptoms may be mistaken for other morbidities. Recent advancements in diagnosis, staging, and therapies have led to improvements in response rates and control of symptoms. This educational activity will review the newer treatment options for newly diagnosed patients taking into consideration recent guideline recommendations. Strategies for the management of patients who develop adverse effects and treatment complications will also be explained.
Time for questions and answers from the webinar audience will be provided at the end of the presentation.
At the conclusion of this application-based continuing education activity, participants should be able to
- Review the pathophysiology and epidemiology of multiple myeloma.
- Outline considerations in the diagnostic work-up and review of treatment options for a newly diagnosed patient with multiple myeloma.
- Outline a plan for involving pharmacists in the overall management of patients with multiple myeloma.
- Consider the implications of recent clinical trials and treatments when developing treatment options for patients with multiple myeloma.
Clinical Specialist, Bone Marrow Transplant
Chapel Hill, North Carolina
Tippu Khan, Pharm.D., BCOP, CPP, is Clinical Specialist in Bone Marrow Transplant (BMT) at University of North Carolina (UNC) Hospitals and Adjunct Clinical Assistant Professor at UNC Eshelman School of Pharmacy in Chapel Hill, North Carolina. In addition, he serves as Resident Advisor for the postgraduate year one (PGY-1) and two (PGY-2) residency programs at UNC Hospitals. Prior to coming to North Carolina, Dr. Khan was Clinical Pharmacy Specialist in Leukemia and BMT for Shands Healthcare at the University of Florida and Adjunct Clinical Assistant Professor at the University of Florida College of Pharmacy in Gainesville, Florida.
Dr. Khan received his Doctor of Pharmacy degree from Purdue University School of Pharmacy and Pharmaceutical Sciences in West Lafayette, Indiana. His postgraduate training consisted of a pharmacy practice residency accredited by the American Society of Health-System Pharmacists (ASHP) at Wishard Health Services/Purdue University and an ASHP-accredited specialty residency in hematology/oncology at Clarian Health Partners in Indianapolis, Indiana. Dr. Khan is currently working on his Master of Healthcare Administration degree at the University of North Carolina Gillings School of Global Public Health in Chapel Hill.
Dr. Khan is a board-certified oncology pharmacist (BCOP) and Certified Pharmacy Practitioner (CPP). As faculty for the American College of Clinical Pharmacy (ACCP)/ASHP Oncology Pharmacy Preparatory Review Course, he lectures on the topics of acute leukemias, tumor lysis syndrome, myelodysplastic syndromes, and multiple myeloma. He also is a professional materials reviewer for the ACCP/ASHP oncology review course and the ACCP pharmacotherapy review course.
Frequently Asked Questions for Webinars
What is a live webinar?
A live webinar brings the presentation to you – at your work place, in your home, through a staff in-service program. You listen to the speaker presentation in “real time” as you watch the slides on the screen. You will have the opportunity to ask the speaker questions at the end of the program. Please join the conference at least 5 minutes before the scheduled start time for important announcements.
How do I process my Continuing Pharmacy Education (CPE) credit?
Continuing pharmacy education for this activity will be processed on ASHP’s new eLearning system and reported directly to CPE Monitor. After completion of the live webinar, you will process your CPE and print your statement of credit online at http://elearning.ashp.org/my-activities. To process your CPE, you will need the enrollment code that will be announced at the end of the webinar.
What if I would like to arrange for my colleagues to participate in this webinar as a group?
One person serving as the group coordinator should register for the webinar. That group coordinator will receive an e-mail confirmation with instructions for joining the webinar. A few minutes before the webinar begins, the group coordinator should launch the webinar link. Once the webinar has been activated, the coordinator will have the option to open the audio via VoIP (Voice Over IP) on the webinar toolbar or use a touch tone phone with the provided dial-in information. At the conclusion of the activity, the group coordinator will complete a brief online evaluation and report the number of participants at that site. Each participant will process his or her individual continuing education statement online.
What do I need in order to participate in the webinar?
Computer with internet access and basic system requirements. When you register, the webinar system will assess your system to ensure compatibility.
Telephone to dial the toll-free number and listen to the presentation (if you choose not to use Voice Over IP [VoIP] via your computer).
Webinar System Requirements
Be sure to view the webinar system requirements for Windows, Mac, iOS, and Android prior to the activity.